Crescent Grove Advisors’s Newmont NEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.55M Buy
38,049
+3,591
+10% +$391K 0.3% 72
2026
Q1
$3.73M Buy
34,458
+9,705
+39% +$1.12M 0.36% 69
2025
Q4
$2.47M Buy
24,753
+5,701
+30% +$515K 0.23% 72
2025
Q3
$1.61M Buy
19,052
+14,129
+287% +$985K 0.15% 91
2025
Q2
$287K Buy
+4,923
New +$263K 0.03% 223
2021
Q4
Sell
-4,025
Closed -$219K 301
2021
Q3
$219K Buy
4,025
+811
+25% +$47.8K 0.02% 243
2021
Q2
$204K Buy
+3,214
New +$215K 0.02% 249

Other funds holding NEM

Crescent Grove Advisors's NEM Position: Q2 2026 in Review

Crescent Grove Advisors increased its Newmont (NEM) stake by 10% in Q2 2026, buying an estimated $391K and bringing the position to 38,049 shares worth $3.55M. The position accounts for 0.3% of the portfolio, ranked #72.

Crescent Grove Advisors first reported a position in NEM in Q2 2021 and has held it in 7 quarters since. The position peaked at $3.73M in Q1 2026. 1,783 funds tracked by Wall St. Rank hold NEM as of Q2 2026.

  • Crescent Grove Advisors held 38,049 shares of Newmont worth $3.55M as of Q2 2026.
  • Crescent Grove Advisors bought 3,591 Newmont shares in Q2 2026, an estimated $391K.
  • Newmont made up 0.3% of Crescent Grove Advisors's portfolio in Q2 2026, its #72 holding.
  • Crescent Grove Advisors first reported a position in Newmont in Q2 2021 and has held it in 7 quarters since.
  • Crescent Grove Advisors's Newmont position peaked at $3.73M in Q1 2026.
  • 1,783 funds tracked by Wall St. Rank held Newmont as of Q2 2026.

Based on Crescent Grove Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.